An introduction to the major concepts and principles of pharmacoeconomics, this book emphasizes modeling, methodologies, and data sources and how to apply them to real world dilemmas. It covers the international use of pharmacoeconomics in drug regulation, drug approval, and pricing. The author provides examples of pharmacoeconomic models used to support these purposes in government, the pharmaceutical industry, and healthcare settings. The book demonstrates the full range of ethical, moral, public health, and commercial concerns that are often involved in decisions involving pharmacoeconomic issues.
Introduction to Pharmacoeconomics, W. F. McGhan Decision Modeling Techniques, M. S. Roberts and K. J. Smith Cost of Illness, R. J. G. Arnold Markov Modeling in Decision Analysis, J. R. Beck Retrospective Database Analysis, R. J. G. Arnold and S. Balu What is Cost-Minimization Analysis?, A. Haycox Cost-Effectiveness Analysis, K. J. Smith and M. S. Roberts Budget Impact Analysis, L. Annemans Cost-Utility Analysis: A Case Study of a Quadrivalent Human Papillomavirus Vaccine, E. J. Dasbach, R. P. Insinga, and E. H. Elbasha Some Problems/Assumptions in Pharmacoeconomic Analysis, S. Birks Patient-Reported Outcome Measures, D. Bryant, G. Guyatt, and R. J. G. Arnold Sensitivity Analysis, M. J. Postma Use of Pharmacoeconomics in Drug Reimbursement in Australia, Canada, and the United Kingdom: What Can We Learn from International Experience?, M. Drummond and C. Sorenson Pharmacoeconomics in Disease Management: Practical Applications and Persistent Challenges, R. Suh and D. Atkins Computer Aided Decision Making from Drug Discovery to Pharmacoeconomics, S. Ekins and R. J. G. Arnold Speculations on the Future Challenges and Value of Pharmacoeconomics, J. J. Caro, D. Getsios, and R. L. Fleurence Index